Assignee profile:

MAPREG

City:

Le Kremlin Bicetre

Country:

France

Published Applications:

9

Last publication date:

2021-10-21

Patent Grants:

7

Last grant date:

2021-08-03

Top Inventors for applications by MAPREG

These are the the leading inventors for applications assigned to MAPREG:

Recent patent applications by MAPREG

MAPREG based in Le Kremlin Bicetre, FR has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2021-10-21
US20210322443A1
Human necessities

NON-BIOCONVERTIBLE C3-SUBSTITUTED PREGNENOLONE DERIVATIVES FOR USE IN THE TREATMENT OF SUBSTANCE USE DISORDERS

#2 | 2018-11-08 ✅ Patent 11,077,122 granted on 2021-08-03
US20180318317A1
Human necessities

Non-bioconvertible C-substituted pregnenolone derivatives for use in the treatment of substance use disorders

#3 | 2017-09-07 ✅ Patent 9,943,528 granted on 2018-04-17
US20170252358A1
Human necessities

Non-bioconvertible C-substituted pregnenolone derivatives for use in the treatment of treatment-resistant depression

#4 | 2016-06-16 ✅ Patent 10,561,671 granted on 2020-02-18
US20160166586A1
Human necessities

Method for treating a degenerative disease of the nervous system using 3-methoxy-pregnenolone or derivatives thereof

#5 | 2014-08-14 ✅ Patent 9,339,508 granted on 2016-05-17
US20140228336A2
Human necessities

Use of 3-methoxy-pregnenolone for the preparation of a drug for treating a traumatic brain injury

#6 | 2014-02-13 ✅ Patent 9,339,508 granted on 2016-05-17
US20140045807A2
Human necessities

THE USE OF 3-METHOXY-PREGNENOLONE FOR THE PREPARATION OF A DRUG FOR TREATING A TRAUMATIC BRAIN INJURY

#7 | 2013-09-19
US20130244991A1
Human necessities

USE OF 3-METHOXY-PREGNENOLONE FOR THE PREPARATION OF A DRUG FOR TREATING DEPRESSIVE DISORDERS AND LONG-TERM NEUROLOGICAL DISEASES

#8 | 2009-06-04 ✅ Patent 8,334,278 granted on 2012-12-18
US20090143347A1
Human necessities

Use of 3-methoxy-pregnenolone for the preparation of a drug for treating depressive disorders and long-term neurological diseases

#9 | 2006-09-07 ✅ Patent 8,034,798 granted on 2011-10-11
US20060199790A1
Human necessities

Use of 3-methoxy-pregnenolone in the production of a medicament for treating neurodegenerative diseases

Also check out MAPREG's (Le Kremlin Bicetre, France) applicant profile with 5 patent applications submitted.

AssigneeID:

39605 ⎘